Pharmacokinetics and safety of OBI-1, a recombinant B domain-deleted porcine factor VIII, in subjects with haemophilia A.
Haemophilia., Sep;18(5):798-804 (2012)
Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand disease.
J. Thromb. Haemost., Jul;10(7):1425-32 (2012)
Critical von Willebrand factor A1 domain residues influence type VI collagen binding.
J. Thromb. Haemost., Jul;10(7):1417-24 (2012)
Von Willebrand disease in the United States: a perspective from Wisconsin.
Semin. Thromb. Hemost., Jul;37(5):528-34 (2011)
Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres.
Haemophilia., Jul;17 Suppl 1:6-13 (2011)
The pharmacokinetic diversity of two von Willebrand factor (VWF)/ factor VIII (FVIII) concentrates in subjects with congenital von Willebrand disease. Results from a prospective, randomised crossover study.
Thromb. Haemost., Aug;106(2):279-88 (2011)
Naturally occurring CD4+ T-cell epitope variants act as altered peptide ligands leading to impaired helper T-cell responses in hepatitis C virus infection.
Hum. Immunol., May;72(5):379-85 (2011)
Hepatitis C virus induces regulatory T cells by naturally occurring viral variants to suppress T cell responses.
Clin. Dev. Immunol., 2011:806061 (2011)
Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD.
Blood., Feb;117(6):e67-74 (2011)
Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor.
Blood., Jul;116(2):280-6 (2010)
Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function.
J. Thromb. Haemost., Nov;7(11):1832-9 (2009)
Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain.
J. Clin. Invest., Mar;119(3):504-11 (2009)
Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets.
Blood., Oct;112(7):2780-6 (2008)
Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival.
Blood., Nov;108(10):3344-51 (2006)
Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A: results of an international clinical investigation.
Thromb. Haemost., Mar;93(3):457-67 (2005)
Epitopes of the NS3 protein of hepatitis C virus: recognition in HLA-DR4 transgenic mice.
Immunol. Cell Biol., Feb;80(1):106-12 (2002)
Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
Thromb. Haemost., Dec;80(6):912-8 (1998)
Hyponatremia and seizures in young children given DDAVP.
Am. J. Hematol., Jul;31(3):199-202 (1989)